MACGT SECRETARIAT
D7-3-1 Block D7, Pusat Perdagangan Dana 1,
Jalan PJU 1A/46, PJU 1A, 47301 Petaling Jaya,
Selangor Darul Ehsan
|
Immuno-Onco SE Asia Ltd
| Address : |
Unit Level 4(A) Main Office Tower,
Financial Park Labuan Jalan Merdeka,
87000 Labuan Federal Territory
|
|
| Telephone : |
|
| Fax : |
|
| |
|
| |
|
|
 |
Dr Lim Teck Onn
A graduate of MBCHB University of Glasgow, MRCP (UK), FRCP (Edinburgh) and a Master of Medical Statistics from the University of Newcastle Australia.
Formerly director of the Clinical Research Centre Ministry of Health Malaysia, he presently serves as consultant to Government agencies and Universities, as well as the Biotech/Pharmaceutical and Healthcare industry in variety of areas including Health research, Biostatistics and Healthcare Performance measurement
Dr Lim has been a WHO Consultant for clinical research to China (TCM Research Institute Beijing 2002-2003), consultant on clinical research to the Aga Khan University (2005 and 2006), University Medical Centre HCM & MOH Vietnam (2007, 2008), Ministry of Health Brunei (2007, 2008), King Saud University College of Medicine Saudi Arabia (2009), University of Ruhuna Sri Lanka (2010).
His other appointments include as Adjunct Professor at IMU, subject editors for various medical journals.
Throughout his career he has been active conducting clinical research and in establishing patient registries. He has more than 60 research publications in reputable international journals
|
Cryocord Sdn Bhd
| Address : |
Suite 1-1, 1st Floor, Bio-X Centre, Persiaran Cyberpoint Selatan, Cyber 8, 63000 Cyberjaya, Selangor, Malaysia |
 |
| Telephone : |
03-8689 8888 |
| Fax : |
03-8689 8866 |
| Website : |
www.cryocord.com.my |
| |
|
|
 |
Mr James Then Khong Lek
Managing Director
Mr James Then Khong Lek provides leadership and oversees strategic management in Cryocord. He is an economics graduate from UK and has worked for Shell Malaysia in operational management. He holds several directorships in various companies which involved in multitude of industries. |
 |
Low Hun Ngee
Director
Mr Henry Low Hun Ngee is a qualified Biochemist graduated from UK. His past and present career involved in MNCs, Public listed companies & local companies range from healthcare, biotech, chemicals, education & training, properties, international trading, F&B industry. He is an important element for the group in corporate affairs, M&As, strategic planning in international business expansion. He sits in numerous companies within the Cryocord group. |
| |
Dr Then Kong Yong
Assistant Lab Director Dr Then Kong Yong graduated with a medical degree from the University of London. He earned a masters degree in molecular and cellular biology from his Alma Mater, and did a fellowship in cellular and tissue engineering at Keele University. He is also a fellow at the Royal College of Surgeons, Edinburg and has completed his higher specialist training in Birmingham, UK. He has pioneered Osteo. Odontho.Keraptoptosthesis. in Malaysia. |
Stemlife Berhad
| Address : |
Address: B-8-15, Megan Avenue II, 12 Jalan Yap Kwan Seng, 50450 Kuala Lumpur, Malaysia |
 |
| Telephone : |
603-2779 0033 |
| Fax : |
03-21649808 |
| Website : |
www.stemlife.com |
| |
|
|
| |
Established in 2001, StemLife Berhad (“StemLife” or the “Company”) is Malaysia’s pioneer private stem cell bank. The Company is a subsidiary of Cordlife Group Limited (“Cordlife”, together with its subsidiaries, the “Group”), a Singapore Exchange-listed company that operates the largest network of stem cell banks in Asia and has earned the trust of over 600,000 parents. StemLife and the Group have facilitated cord blood releases to 18 healthcare institutions across 10 countries, supporting stem cell transplants and cellular therapies. StemLife is committed to ensuring that their clients can use their cord blood anywhere in the world by obtaining a licence from the Malaysian Ministry of Health and accreditation from the AABB, a global leader in establishing patient safety standards for blood banking, transfusion medicine, blood management, and cellular therapies. Beyond cord blood banking, StemLife offers cryopreservation services for cord lining, cord tissue, and umbilical cord mesenchymal stem cells, along with stem cell expansion through collaboration with a cGMP laboratory. The Company also provides various diagnostic services, including non-invasive prenatal testing (NIPT), chromosomal microarray analysis, newborn metabolic screening and talent genetic screening. For more information, please visit www.stemlife.com. |
 |
Ms. Tan Sock Pin
Chief Executive Officer
|
 |
Prof Dr Menaka @ Mannaha A/P Hariharan
Medical Director
|
 |
Mr Zahrein Redza Bin Mohammed Redza
Chief Operating Officer
|
KLSMC Stem Cells Sdn Bhd
| Address : |
7th Floor, Wisma Perintis, 47, Jalan Dungun, Damansara Heights, 50490, Kuala Lumpur |
 |
| Telephone : |
03-20961033 |
| Fax : |
03-20958500 |
| Website : |
klsmc.com |
| |
Dr Caroline Jee
(Chief Scientific Officer) |
| |
Amal Mohd Dawam
(Research Assistant) |
| |
Alisha Nurdiyanah Ramlan Hussain
(Junior Research Assistant) |
Nichi-Asia Life Science Sdn Bhd
| Address : |
No. 57, Block F, Jalan Technology 3/9, Bistari 'DE' Kota, Kota Damansara PJU5, 47810 Petaling Jaya. |
 |
| Telephone : |
03-61421920/ 21 |
| Email : |
enquiry@niscell.com |
| Website : |
www.niscell.com |
| |
Mr Sitsa Velautham
(CEO/CFO) |
| |
Dr. Sellamuthu Gounder Subbana
(Chief Scientist) |
Intran Technologies Sdn Bhd
| Address : |
Intran Technologies Sdn Bhd, 33 Block L, Jalan PJU 1A/1, Taipan Damansara 2 Parcel 3, Ara Damansara, 47301 Petaling Jaya, Selangor |
 |
| Telephone : |
03-78429204 / 03-78427371 |
| Fax : |
03-78429203 |
 |
Mr Padmanabhan Mahalingam
(Managing Director) |
CG Therapeutics Sdn Bhd
| Address : |
T2A-18-13 Menara 3, 296 Jalan Ampang, 50450 Kuala Lumpur, Malaysia |
|
| Telephone : |
|
| Email : |
CGT202323@gmail.com |
| Website : |
|
|
CG Therapeutics Sdn Bhd
CG Therapeutics Sdn Bhd (CGT) is a start up company specializing in the Clinical research and commercialization of advanced cell and gene therapies. We are dedicated to revolutionizing healthcare by harnessing the power of cellular and genetic technologies to provide innovative treatments for a wide range of diseases that involved in Cancer treatment and gene deficient diseases
Dr Wong Yong Yee
Dr Wong Yong Yee, PhD in Molecular Biology (National University of Singapore), founder of DNA Laboratories Sdn Bhd (DNA LAB), the pioneer of medical diagnostics Laboratory in Malaysia. DNA LAB was acquired by a US based global medical device and genomic company in 2018. Dr Wong is an entrepreneur, molecular cellular geneticist that is currently pursuing his mission to cure genetic disease and cancer by using Cell and Gene Therapy treatment.
|
Cytomed Therapeutics (Malaysia) Sdn Bhd
| Address : |
12, Jalan Permas 9/16, bandar Baru Permas jaya, 81750 Johor |
 |
| Telephone : |
asdasdasd |
| Website : |
w2.cytomed.sg |
 |
Ms Evelyn Tan
Director
Evelyn has experience in handling corporate restructuring and acquisitions, and has participated heavily in the due diligence process of a millions worth sale of gold mining company to a Singapore listed company. Her main tasks are to assist with human resource, finance, business administration and management, as well as legal compliance of the Company. She obtained her Bachelor of Law (LL.B.) from Jinan University, China, and Masters of Law (LL.M.) from the University of Aberdeen, United Kingdom, before completing Graduate Diploma in Law and Legal Practice Course from the BPP Law School, United Kingdom |
Malaysian Genomics Resources Centre Berhad
| Address : |
8F, Jalan Teknologi 316, Taman Sains Selangor, PJU5 Kota Damansara, 47810 Petaling Jaya |
 |
| Telephone : |
03-7890 0015 |
| Website : |
www.immunotherapy.life |
| |
En Noor Azri bin Dato' Sri Noor Azerai
(Executive Director) |
| |
Mr Sasha Omar Nordin
(CEO)
|
|
Dr Eunice Pui Wan Wen
(Head of Medical Affairs) |
CELL 101 International Sdn Bhd
| Address : |
Block B-0-9, Casa Tropicana, No. 5 Jalan Persiaran Tropicana, Tropicana Golf and Resort, 47410 Petaling Jaya, Selangor Darul Ehsan |
 |
| Telephone : |
011-16251265 |
| Website : |
www.cell101.com.my |
| Email : |
cell101.international@gmail.com |
 |
Dr. Rubben
Founder and Chief Executive Officier
- Founded Cell 101 International in February 2022
- Founder of Klinik Medicka since 2016
- Registered Medical Practitioner with more than 14 years of experience
- Experience in using Cellular Products for almost 10 years
- Lectured and trained more than 100 doctors in Regenerative & Cellular Therapies
- Co-founded the AS Group of companies in July 2021
- Established proper guidelines & techniques for Cellular Therapies that are currently being used by many practitioners
- Member of the Malaysian Society of Stem Cells Research and Therapy
- Awarded as Cellular Tech Provider of the Year by Global Health Awards
|
 |
Muhammad Mazli
Chief Operating Officier
- Background in multiple fields, including Operations, Sales & Marketing, Communications, Banking, Entertainment and many other industries
- Resourceful and has built good relationships with many industry players
- Currently manages his own pdcast and has a good fellowship
- Also involved with many NGOs and some political bodies
- A core team member of Cell101, mainly handling operations and management
- Involved in building a comprehensive management system for the company to ease administrative works and operation tasks
- Persistent, handworking, and positive minded-believes in the potential of the cellular and regenerative industry
|
 |
Ms. Sharen Aini
Head of Production & Development
PROJECT LEADER AT CELL 101 - CUTTING-EDGE MODULAR LAB DEVELOPMENT
- Leading Innovation: Developing the region's most advanced modular laboratory for Cell 101
- Educational background: Master's in Medical Science, specializing in Physiology from Universiti Kebangsaan Malaysia.
- Stem Cell Expertise: Over a decade in stem cell technology for therapeutic applications
- cGMP Compliance: 8+ years ensuring adherence to current Good Manufacturing Practice standards in tissue engineering and regenarative medicine
- Quality Assurance: Maintains high regulatory compliance and quality standards in stem cell-based theraphy production and development.
Drives innovation and quality in modern regenerative medicine facilities.
|
|
